• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Longtop Financial Technologies Limited ADR

Longtop Financial Technologies Limited ADR

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. Alnylam Presents Results from Natural History Study of Patients with Familial Amyloidotic Cardiomyopathy (FAC) and Presents Complete Results from Phase 2 Clinical Trial for Revusiran, an ...

    Alnylam Presents Results from Natural History Study of Patients with Familial Amyloidotic Cardiomyopathy (FAC) and Presents Complete Results from Phase 2 Clinical Trial for Revusiran, an Investigational RNAi Therapeutic for the Treatment of FAC

  2. Fidelity and Putnam Among Fund Families Duped by Longtop

    Longtop's great growth seduced some of the biggest fund names.

  3. A Closer Look at a Trio of Cellar-Dwellers

    Fairholme Fund isn't the only one struggling in 2011.

Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.